Happy Holidays from Oregon Bioscience Incubator!
To observe the holidays and spend time with our families, OBI/OTRADI will be closed December 23-January 2. We wish you all a joyful holiday season and a happy start to 2023!
Rene Miller Promoted to OBI Associate Director
Following the departure of Hazel Valdez, Rene Miller has been promoted to the Associate Director position. Rene first joined the Oregon Bioscience Incubator/OTRADI in January 2020. As Associate Director, Rene recruits and helps select new client companies to join the incubator, implements and markets community and client programs and events, leads DEI initiatives, and manages communications and social media outreach.
Rene holds Bachelor of Science degrees in Business from Portland State University and Clinical Laboratory Science from Oregon Health & Science University/Oregon Institute of Technology, as well as a Master of Science in Nutrition from University of Western States. Her background includes clinical laboratory experience and small business ownership. As a longtime Chamber of Commerce participant, she also brought her interest in supporting and encouraging business growth and development to the OBI.
Welcome GenerX to the OBI
GenerX, a pharmaceutical development company, has moved its headquarters from California to the OBI. GenerX is engaged in the development, manufacturing, acquisition, licensing, and partnership of sterile injectable generic drug products for the U.S. and overseas markets. Their mission is to provide affordable generic medicines to patients through innovative solutions by leveraging our expertise and partnerships with world class FDA approved manufacturing facilities.
GenerX moved into one of our brand new labs on December 1, and we are thrilled to have them join us!
Client Company Wins
- Keliomics was one of the five winners of the Beaverton Startup Challenge 2023, winning $25,000.
- Synergic is proud to announce that we have received breakthrough device designation from the FDA! This is a big day for us in our mission of bringing solutions to the Parkinson’s community. We appreciate this special recognition and support of the FDA in our on-going development of the VT Touch.
- Gamma Diagnostics Inc. is proud to announce that Mr. Ajay Nair, currently President and CEO, will serve as Chairman of the Executive Board and transition the Chief Executive Officer role to Mr. Chris Venter, currently CFO of the Company, effective November 18th, 2022.
- SUTUREGARD wins American Diabetes Association 2022 Showcase Innovation Award. We were recently (November 4, 2022) honored to receive this award, having successfully competed with 160 other companies from the USA and beyond. Above we are receiving the award presented by Dr. Robert Gabbay, the Chief Medical Officer of the ADA (2nd from L). The ADA heard our message about how our HEMIGARD product has dramatically improved surgical outcomes for diabetic amputation patients.
- As you may know, many initial amputations do not heal on these patients who almost always have vascular disease and neuropathy, and often require more morbid above or below knee amputations with high risk of systemic complications including mortality. HEMIGARD reduced need for further amputation by 89% by preventing healing complications with the initial amputation. This study of 80 patients is valid real world evidence that resonated with the ADA judges.
- We look forward to bringing HEMIGARD to all those who do provide surgical care for diabetics with the goal of improving their surgical outcomes!
- GenerX moved its headquarters from Santa Clara, CA into the OBI in Portland on December 1.
- StoneStable is hiring a part-time technician. See their job description here.
Congratulations on all of your achievements!
VertueLab’s Federal Funding News
VertueLab’s December newsletter is chock full of federal funding opportunities and resources, such as:
- Department of Energy (DOE)
- National Science Foundation (NSF)
- National Oceanographic and Atmospheric Administration (NOAA)
- Department of Homeland Security (DHS)
- Department of Defense (DoD)
As one of Oregon’s signature research centers (alongside OTRADI and ONAMI), VertueLab is always there to help Oregon entrepreneurs with helpful information and free advice.
Partner Spotlight: Northwest Tenant Group
Stanford Scriven is the founder and principal of Northwest Tenant Group, Portland’s only independent, conflict-free real estate firm. His approach is that of a “Chief Real Estate Officer” for Northwest companies who need to utilize real estate without the headache. He has proudly managed real estate projects for over 100 companies ranging from startups to the Fortune 150. Learn more about Northwest Tenant Group’s services at www.nwtenantgroup.com.
Upcoming Events
OBI events
Accelerate Biotech + Digital Health Happy Hour
January 5, 2023
5:30-7:00 PM
Marriott Courtyard City Center
Register here – tickets are going fast!
Other community partner events
OEN Pub Talk: Exit Strategies Realized… Now What?
December 14, 2022
5:15-7:30 PM
Holcene
Get tickets here
PDX Women in Tech Winter Soiree & Awards Ceremony
December 15, 2022
5:00-7:00 PM
In-person or virtual
Register here